New CE mark in the European Union extends application of Ventana system to routine pathology, including primary diagnosis with human tissue specimens.
The Xradia 520 Versa 3D x-ray microscope from Carl Zeiss Microscopy was designed for non-destructive in situ 3D imaging of hard-to-image materials and their microstructures, enabling compositional probing for features often indistinguishable in a single scan.
The AcroMetrix Oncology Hotspot control from Thermo Fisher Scientific can be used across laboratories with different NGS instrument platforms, assays, and bioinformatics pipelines to test precision and detect analytical deviations that may arise from reagent and instrument variation.
The Accurun 501 C. difficile control from SeraCare Life Sciences is ready to use in assays that detect C. difficile DNA with any transport system.
CAP ’14, the College of American Pathologists annual meeting, September 7–10, will feature advances in molecular medicine, genetic testing, and laboratory technologies.
Scientists at the Houston Methodist Research Institute have figured out how to pick up and transfer single cells using a pipette—a common laboratory tool that’s been tweaked slightly.
NIH-supported study suggests that early diagnosis of severe combined immunodeficiency leads to high survival rates.
The August 2014 guide highlights molecular testing products from companies including Abbott Molecular, Randox, and Thermo Fisher Scientific.
A number of drivers are changing the pathology and laboratory medicine landscape, including workforce shortages and technology advances such as digital microscopy.
Cernostics has developed TissueCypher image analysis software to improve testing for Barrett’s esophagus, a precancerous condition that is considered a precursor to esophageal cancer.